Scholarly Index
Paul Chang
Aratana Therapeutics (United States); 4,562 total citations; 85 total publications; best world rank #493
Aratana Therapeutics (United States)
4,562Total citations
85Total publications
28H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| PARP inhibition in cancer therapy | Lifetime | 493 | US 231 | 94.67 |